China Resources Pharmaceutical Group Limited (FRA:640)

Germany flag Germany · Delayed Price · Currency is EUR
0.4800
-0.0300 (-5.88%)
At close: Feb 20, 2026
Market Cap3.10B -22.7%
Revenue (ttm)31.02B +4.2%
Net Income332.79M -25.3%
EPS0.05 -25.5%
Shares Outn/a
PE Ratio9.33
Forward PE7.02
Dividend0.01 (3.11%)
Ex-Dividend DateSep 11, 2025
Volume947
Average Volume99
Open0.5100
Previous Close0.5100
Day's Range0.4800 - 0.5100
52-Week Range0.4660 - 0.6550
Betan/a
RSI45.01
Earnings DateMar 26, 2026

About FRA:640

China Resources Pharmaceutical Group Limited, an investment holding company, engages in the manufacture, distribution, and retail of pharmaceutical and other healthcare products in Mainland China and internationally. It operates through four segments: Pharmaceutical Manufacturing, Pharmaceutical Distribution, Pharmaceutical Retail, and Others. The company offers a range of chemical drugs, Chinese medicines, and biological drugs, as well as nutritional and healthcare products for various therapeutic areas, including cardiovascular and cerebrovas... [Read more]

Industry Pharmaceutical Preparations
Founded 2007
Employees 86,000
Stock Exchange Frankfurt Stock Exchange
Ticker Symbol 640
Full Company Profile

Financial Performance

In 2024, FRA:640's revenue was 257.67 billion, an increase of 5.30% compared to the previous year's 244.70 billion. Earnings were 3.33 billion, a decrease of -13.57%.

Financial numbers in CNY Financial Statements